Rui Yang
Central South University(CN)Harbin Medical University(CN)Hangzhou Normal University(CN)Guangdong Pharmaceutical University(CN)Heilongjiang University of Chinese Medicine(CN)Jilin University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Huazhong Agricultural University(CN)Sichuan University(CN)State Administration of Traditional Chinese Medicine of the People's Republic of China(CN)Peking Union Medical College Hospital(CN)West China Hospital of Sichuan University(CN)Shanghai University of Traditional Chinese Medicine(CN)Longhua Hospital Shanghai University of Traditional Chinese Medicine(CN)Shanxi Provincial Cancer Hospital(CN)Third Affiliated Hospital of Harbin Medical University(CN)Guangdong Provincial Hospital of Traditional Chinese Medicine(CN)Hubei University for Nationalities(CN)The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture(CN)Minda Hospital(CN)Tasly Holding Group (China)(CN)Cancer Hospital of Chinese Academy of Medical Sciences(CN)Fu Wai Hospital(CN)State Key Laboratory of Supramolecular Structure and MaterialsLanzhou University(CN)Rockefeller University(US)
Publications by Year
Research Areas
Immune Cell Function and Interaction, Immunodeficiency and Autoimmune Disorders, T-cell and B-cell Immunology, Cancer-related molecular mechanisms research, Mycobacterium research and diagnosis
Most-Cited Works
- → Autoantibodies against type I IFNs in patients with life-threatening COVID-19(2020)2,815 cited
- → Inborn errors of type I IFN immunity in patients with life-threatening COVID-19(2020)2,377 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer(2020)516 cited
- → Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine(2021)228 cited
- → The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies(2022)183 cited